|Articles|October 1, 2001
Silicone IOL maintains good results at 3-year follow-up
Pittsburgh-Three-year follow-up data show the CeeOn 911A siliconefoldable IOL (Pharmacia) continues to provide excellent visual acuity andhas been associated with no significant lens-related problems and remarkablyminimal posterior capsule opacification, said William C. Christie, MD, aprivate practitioner from Pittsburgh.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
SubscribeAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FDA grants RMAT designation to Emmecell's EO2002 for corneal endothelial disease
2
Opus Genetics reaches FDA alignment on phase 3 registrational design for OPGx-LCA5 gene therapy
3
NeuroOp Guru: What a big data study reveals about NAION and stroke risk
4
Port Delivery System Therapies in Retinal Vascular Diseases
5


















